Trial intelligence / Profile preview

Dexmedetomidine for Post-Cesarean Section Pain Control

IRCT20191021045175N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine in postoperative pain, sponsored by Mashhad University of Medical Sciences. Primary endpoint: Duration of analgesia after spinal anesthesia. Started Dec 2019; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20191021045175N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191021045175N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call